N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide

C102H145N7O7S — CID 162200783

IUPACN-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide
SMILESCC(=O)N(C)CCC1(c2ccc(C)cc2)CCC1.Cc1ccc(C2(CCN3CC=CC3=O)CCC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CCC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CCC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CCC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CCC2)cc1
InChIInChI=1S/C18H27NO.C17H24N2O.C17H25NO2S.C17H21NO.C17H25NO.C16H23NO/c1-15-3-5-16(6-4-15)18(9-2-10-18)11-14-19-12-7-17(20)8-13-19;1-14-3-5-15(6-4-14)17(7-2-8-17)9-11-19-12-10-18-16(20)13-19;1-15-3-5-16(6-4-15)17(7-2-8-17)9-10-18-11-13-21(19,20)14-12-18;1-14-5-7-15(8-6-14)17(9-3-10-17)11-13-18-12-2-4-16(18)19;1-13(2)16(19)18-12-11-17(9-4-10-17)15-7-5-14(3)6-8-15;1-13-5-7-15(8-6-13)16(9-4-10-16)11-12-17(3)14(2)18/h3-6,17,20H,2,7-14H2,1H3;3-6H,2,7-13H2,1H3,(H,18,20);3-6H,2,7-14H2,1H3;2,4-8H,3,9-13H2,1H3;5-8,13H,4,9-12H2,1-3H3,(H,18,19);5-8H,4,9-12H2,1-3H3
InChIKeyZROALJJLZCFGMO-UHFFFAOYSA-N
MW1613.39 g/mol
LogP18.11
Rot. Bonds25

About N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide

N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide (PubChem CID 162200783) has the molecular formula C102H145N7O7S and a molecular weight of 1613.39 g/mol. Its IUPAC name is N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide.

Molecular Properties

Compound NameN-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide
PubChem CID162200783
Molecular FormulaC102H145N7O7S
Molecular Weight1613.39 g/mol
Exact Mass1612.09
IUPAC NameN-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide
SMILESCC(=O)N(C)CCC1(c2ccc(C)cc2)CCC1.Cc1ccc(C2(CCN3CC=CC3=O)CCC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CCC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CCC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CCC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CCC2)cc1
InChIInChI=1S/C18H27NO.C17H24N2O.C17H25NO2S.C17H21NO.C17H25NO.C16H23NO/c1-15-3-5-16(6-4-15)18(9-2-10-18)11-14-19-12-7-17(20)8-13-19;1-14-3-5-15(6-4-14)17(7-2-8-17)9-11-19-12-10-18-16(20)13-19;1-15-3-5-16(6-4-15)17(7-2-8-17)9-10-18-11-13-21(19,20)14-12-18;1-14-5-7-15(8-6-14)17(9-3-10-17)11-13-18-12-2-4-16(18)19;1-13(2)16(19)18-12-11-17(9-4-10-17)15-7-5-14(3)6-8-15;1-13-5-7-15(8-6-13)16(9-4-10-16)11-12-17(3)14(2)18/h3-6,17,20H,2,7-14H2,1H3;3-6H,2,7-13H2,1H3,(H,18,20);3-6H,2,7-14H2,1H3;2,4-8H,3,9-13H2,1H3;5-8,13H,4,9-12H2,1-3H3,(H,18,19);5-8H,4,9-12H2,1-3H3
InChIKeyZROALJJLZCFGMO-UHFFFAOYSA-N
XLogP18.11
TPSA162.91 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds25
Heavy Atoms117
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001613.39
LogP ≤ 518.11
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Analyze N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The IUPAC name of N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide (CID 162200783) is N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide.
What is the SMILES notation for N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The canonical SMILES for N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide is CC(=O)N(C)CCC1(c2ccc(C)cc2)CCC1.Cc1ccc(C2(CCN3CC=CC3=O)CCC2)cc1.Cc1ccc(C2(CCN3CCC(O)CC3)CCC2)cc1.Cc1ccc(C2(CCN3CCNC(=O)C3)CCC2)cc1.Cc1ccc(C2(CCN3CCS(=O)(=O)CC3)CCC2)cc1.Cc1ccc(C2(CCNC(=O)C(C)C)CCC2)cc1.
What is the InChIKey of N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide?
The InChIKey is ZROALJJLZCFGMO-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H27NO.C17H24N2O.C17H25NO2S.C17H21NO.C17H25NO.C16H23NO/c1-15-3-5-16(6-4-15)18(9-2-10-18)11-14-19-12-7-17(20)8-13-19;1-14-3-5-15(6-4-14)17(7-2-8-17)9-11-19-12-10-18-16(20)13-19;1-15-3-5-16(6-4-15)17(7-2-8-17)9-10-18-11-13-21(19,20)14-12-18;1-14-5-7-15(8-6-14)17(9-3-10-17)11-13-18-12-2-4-16(18)19;1-13(2)16(19)18-12-11-17(9-4-10-17)15-7-5-14(3)6-8-15;1-13-5-7-15(8-6-13)16(9-4-10-16)11-12-17(3)14(2)18/h3-6,17,20H,2,7-14H2,1H3;3-6H,2,7-13H2,1H3,(H,18,20);3-6H,2,7-14H2,1H3;2,4-8H,3,9-13H2,1H3;5-8,13H,4,9-12H2,1-3H3,(H,18,19);5-8H,4,9-12H2,1-3H3.
What are the key properties of N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide?
N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide has a molecular weight of 1613.39 g/mol, XLogP of 18.11, 25 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]acetamide;2-methyl-N-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]propanamide;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperazin-2-one;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]piperidin-4-ol;1-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-2H-pyrrol-5-one;4-[2-[1-(4-methylphenyl)cyclobutyl]ethyl]-1,4-thiazinane 1,1-dioxide is sourced from PubChem (CID 162200783), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).